ClinicalTrials.gg
RecruitingNCT07717229Updated Jul 21, 2026

Effectiveness of BrightHearts Biofeedback Relaxation and Virtual Reality Distraction During Inferior Alveolar Nerve Block Injection in Children

An interventional study of BrightHearts"biofeedback relaxation tool and Virtual Reality distraction in Dental Anxiety, sponsored by October University for Modern Sciences and Arts. Recruiting at 1 site in Egypt. Open to participants aged 7 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by October University for Modern Sciences and Arts · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Nov 2025, registered Feb 2026).
  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

The study is designed to compare the effectiveness of "BrightHearts" biofeedback relaxation tool versus Virtual Reality distraction and Verbal distraction as a distraction methods in reducing dental anxiety and improving behavior during the inferior alveolar nerve block procedure.

02

Conditions studied

  • Dental Anxiety

Keywords

  • dental anxiety
  • inferior alveolar nerve block
  • brighthearts
  • virtual reality
  • biofeedback
03

In context

Lead sponsor

October University for Modern Sciences and Arts is the lead sponsor of 52 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children from 7 to 12 years
  2. Children who have dental procedures that require an inferior alveolar nerve block injection.
  3. Healthy Children.
  4. Children who fall under Frankl's behavioral rating of 2 (negative) or 3 (positive)

Exclusion criteria

Exclusion Criteria:

  1. Children with special health care needs
  2. Children or parents who are unable or unwilling to cooperate with the study protocol or assessment
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
39 participants (estimated)

Study arms

  • Experimental
    Group A

    Other: BrightHearts"biofeedback relaxation tool

  • Active comparator
    Group B

    Device: Virtual Reality distraction

  • Active comparator
    Group C

    Behavioral: Verbal distraction technique

Interventions

  • OtherBrightHearts"biofeedback relaxation tool

    Before the inferior alveolar nerve block procedure, Participants will be taught to use the application after given instructions. They will be asked to keep a constant color by focusing on breathing slowly, then they will be allowed to use the application a few minutes before the inferior alveolar nerve block procedure

  • DeviceVirtual Reality distraction

    participants in this group will experience Virtual Reality distraction eyewear. After giving an introduction about it, they will be allowed to accommodate, then they will be wearing it during the inferior alveolar nerve block procedure in an environment designed to distract them during the injection. The Virtual Reality distraction content will be age-appropriate and engaging, and feature interactive (e.g., Fun animations, and Cartoons).

  • BehavioralVerbal distraction technique

    The Verbal distraction method technique involves: patient is given an instruction to do in order to divert his/her attention

06

What researchers measure

Primary outcomes

  1. Evaluation of Dental Anxiety.

    Using Heart rate monitor. Heart Rate (beats per minute \[bpm\]) measured using a heart rate monitor. Higher heart rate values indicate greater physiological anxiety.

    Time frame: - Baseline (5 minutes before injection) - During injection - 2 minutes after injection

Secondary outcomes

  1. Evaluation of Dental Anxiety

    Using Facial Image Scale scores range from 1 to 5, with 1 indicating no anxiety (very happy face) and 5 indicating highest anxiety (very unhappy face). Higher scores indicate greater dental anxiety.

    Time frame: Baseline (5 minutes before injection)and immediately after injection.

  2. Behavior Assessment

    FLACC Rating Scale. Face, Legs, Activity, Cry, Consolability (FLACC) Scale. Scores range from 0 to 10, with higher scores indicating greater pain and distress.

    Time frame: During injection

07

Study locations

1 of 1 sites recruiting
  • October University for Modern Science and Arts
    Giza, 12451, Egypt
    Recruiting
    • Naglaa Ibrahim Ezz Eldin, Professor Doctor · Contactniezz@msa.edu.eg · 00201001984184
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2025 (actual). Primary completion is estimated for Aug 2026, 9 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2026
First posted
Jul 21, 2026
StartActual
Nov 15, 2025
Primary completionEst.
Aug 30, 2026
CompletionEst.
Sep 30, 2026
Last update
Jul 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07717229
Lead sponsor
October University for Modern Sciences and Arts
Responsible party
Sara Ahmed Khira (Master degree candidate, October University for Modern Sciences and Arts) — Principal investigator
First posted
Jul 21, 2026
Start date
Nov 15, 2025
Primary completion
Aug 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Jul 21, 2026

Study contacts

Sara Ahmed Khira, Bachelor Degree
Contact
sara.ahmed28@msa.edu.eg
00201012592478

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion